Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,628
datasets available to search
ShareScore release 0.9.0
Dataset results
1,628 results for “type safety”
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)
ClinicalTrials.gov study NCT02036515. IPD Sharing: YES. Countries: 0. Publications: 8.
Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC
ClinicalTrials.gov study NCT04835142. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05775900. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)
ClinicalTrials.gov study NCT00352599. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00099866. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT02529449. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy Study Comparing 3 New Types of Coronary Stents
ClinicalTrials.gov study NCT01166685. IPD Sharing: Not stated. Countries: 4. Publications: 2.
An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.
ClinicalTrials.gov study NCT02350816. IPD Sharing: YES. Countries: 7. Publications: 0.
Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes
ClinicalTrials.gov study NCT03635437. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)
ClinicalTrials.gov study NCT01971554. IPD Sharing: YES. Countries: 0. Publications: 1.
GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT00280865. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1
ClinicalTrials.gov study NCT02312011. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
ClinicalTrials.gov study NCT02794792. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)
ClinicalTrials.gov study NCT00993187. IPD Sharing: YES. Countries: 0. Publications: 1.
Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1
ClinicalTrials.gov study NCT05614531. IPD Sharing: NO. Countries: 1. Publications: 1.
Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes
ClinicalTrials.gov study NCT01661192. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00138541. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More T
ClinicalTrials.gov study NCT00000667. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)
ClinicalTrials.gov study NCT01814748. IPD Sharing: YES. Countries: 0. Publications: 1.
Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%
ClinicalTrials.gov study NCT00101673. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.